RUNX2 and congenital bilateral aplasia of vas deferens from CFTR mutation: In summary, through RUNX2 and Wnt/β-catenin signaling pathway, miR-138-5p acts as a positive regulator of osteogenic differentiation in CAVD patients to involve in inhibiting valve calcification.